Lineage Cell Therapeutics
LCTX
#8221
Rank
NZ$0.26 B
Marketcap
$1.40
Share price
1.22%
Change (1 day)
-34.18%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -NZ$42.04 M

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings (TTM) are -NZ$41.89 M. In 2023 the company made an earning of -NZ$40.48 M a decrease over its 2022 earnings that were of -NZ$36.85 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$42.04 M3.88%
2023 -NZ$40.48 M9.83%
2022 -NZ$36.85 M-54.24%
2021 -NZ$80.53 M86.07%
2020 -NZ$43.28 M-31.97%
2019 -NZ$63.62 M-5.42%
2018 -NZ$67.26 M1.1%
2017 -NZ$66.53 M-31.06%
2016 -NZ$96.5 M-10.38%
2015 -NZ$0.11 B29.69%
2014 -NZ$83.03 M31.68%
2013 -NZ$63.06 M
2011 -NZ$30.6 M89.78%
2010 -NZ$16.13 M206.06%
2009 -NZ$5.27 M-0.58%
2008 -NZ$5.3 M164.89%
2007 -NZ$2.01 M-30.22%
2006 -NZ$2.87 M
2002 -NZ$3.33 M-41.04%
2001 -NZ$5.65 M-32.04%
2000 -NZ$8.31 M-11.85%
1999 -NZ$9.43 M
1997 -NZ$6.06 M12.12%
1996 -NZ$5.4 M106.25%
1995 -NZ$2.62 M-11.11%
1994 -NZ$2.95 M50%
1993 -NZ$1.97 M20%
1992 -NZ$1.64 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.21 B 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA